reviewNew England Journal of MedicineApr 15, 2015Closed access

Clostridium difficile Infection

Beth Israel Deaconess Medical Center

PubMed
Indexed incrossrefpubmed

Abstract

This article reviews the pathogenesis, epidemiology, diagnosis, and treatment of this nosocomial and potentially fatal infectious diarrhea, as well as the associated risk factors. New treatments include fecal microbiota transplantation for disease that is resistant to vancomycin.

Citation impact

1,464
total citations
FWCI
93.13
Percentile
100%
References
131
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Clostridium difficile
  • Fecal bacteriotherapy
  • Diarrhea
  • Vancomycin
  • Epidemiology
  • Intensive care medicine
  • Pathogenesis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.